Scinai Immunotherapeutics (SCNI) Invested Capital (2019 - 2026)
Scinai Immunotherapeutics (SCNI) reported Invested Capital of $354000.0 for Q1 2026, up 7.6% sequentially from $329000.0 in Q4 2025.
Scinai Immunotherapeutics (SCNI) Invested Capital (2019 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 8 years of Invested Capital data on file, last reported at $354000.0 in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital changed N/A year-over-year to $354000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 2.43% YoY), and the FY2025 full-year result was $329000.0, down 22.41% from the prior year.
- Invested Capital grew to $354000.0 in Q1 2026, from $329000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $1.8 million in Q1 2022 to a low of $329000.0 in Q4 2025.
- A 5-year average of $637214.3 and a median of $390500.0 in 2023 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital plunged 99.97% in 2022 and soared 36.54% in 2025, its largest moves.
- Tracing SCNI's Invested Capital over 5 years: stood at $382000.0 in 2022, then advanced by 3.66% to $396000.0 in 2023, then advanced by 7.07% to $424000.0 in 2024, then fell by 22.41% to $329000.0 in 2025, then advanced by 7.6% to $354000.0 in 2026.
- Business Quant data shows SCNI's Invested Capital at $354000.0 in Q1 2026, $329000.0 in Q4 2025, and $497000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | 354,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 354,000.00 |
| Dec 31, 2025 | 329,000.00 |
| Jun 30, 2025 | 497,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Sep 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 364,000.00 |
| Mar 31, 2024 | 387,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Sep 30, 2023 | 382,000.00 |
| Jun 30, 2023 | 394,000.00 |
| Dec 31, 2022 | 382,000.00 |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.76 Mn |
| Dec 31, 2021 | 375,000.00 |
| Sep 30, 2021 | 1.83 Mn |
| Jun 30, 2021 | 6.05 Bn |
| Mar 31, 2021 | 5.98 Bn |
| Dec 31, 2020 | 6.09 Bn |
| Sep 30, 2020 | 1.82 Mn |